Cincinnati.com: COVID on the rise: Cincinnati doctors weigh in on masks, vaccines as winter approaches
UC expert recommends continuing to take precautions
As cooler fall weather rolls into the Cincinnati region, COVID-19 cases are on the rise and we can expect to see the seasonal impact of the cold and flu season. Cincinnati.com interviewed several local doctors to ask about wearing masks and getting the latest vaccines. One of those was Jennifer Forrester, MD, of the Division of Infectious Diseases at the UC College of Medicine.
One of the topics of discussion was the increase in wearing of masks and if masking mandates would return.
Jennifer Forrester, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Colleen Kelley/UC Marketing + Brand
"I doubt masking mandates will be seen in most places, but people will likely be making their own risk assessments based on where they will be and with whom," Forrester said. "Some hospitals have already instituted masking again, and others are considering it. I will be masking to protect my patients, myself and my family, too."
All the experts interviewed for the story said they planned on getting the new COVID-19 vaccine as soon as it is available.
"My whole family and I plan to get the vaccine as soon as it is available," said Robert Frenck, MD, director of Cincinnati Children's Vaccine Research Center. "I am going to try to get it along with my yearly flu vaccine."
The expert panel was also asked what people should know as we encounter this increase in COVID-19 cases.
"Washing hands, staying home when sick and getting vaccinated are all tools to protect yourself, your family and friends and our community from many different illnesses that are more common this time of year," said Forrester.
Lead photo/Stephanie Murton/Getty Images
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.